Cerebrovascular Myosin Light Chain Phosphorylation in Fetus, Newborn, and Adult

胎儿、新生儿和成人的脑血管肌球蛋白轻链磷酸化

基本信息

  • 批准号:
    8448654
  • 负责人:
  • 金额:
    $ 28.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-15 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cardiovascular instability is one of the most difficult challenges in clinical management of pre-term infants due to unique neonatal patterns of cardiovascular reactivity, particularly in the cerebral circulation. Compared to adult arteries, immature cerebral arteries exhibit greater reliance on Ca++ influx than on intracellular Ca++ release for initiation of contraction, but also exhibit markedly enhanced myofilament Ca++ sensitivity. One possible explanation for this enhanced fetal myofilament Ca++ sensitivity is that phosphorylation of regulatory myosin light chain (MLC20), a key contractile protein, is upregulated in immature cerebral arteries. Previous attempts to study phosphorylation of MLC20 in situ have been limited by technical barriers, including the inability to measure the rapid time course of MLC20 phosphorylation in intact arteries. Methods recently developed in the applicant's laboratory have surmounted these problems. A custom designed apparatus now can simultaneously measure cytosolic Ca++ transients and MLC20 phosphorylation with millisecond resolution in intact arteries in a cuvette small enough to accommodate fetal cerebral arteries. Protein expression systems are now available that can produce single isoforms of MLC20 in quantities suitable for kinetic measurements. New confocal colocalization methods are capable of resolving interactions among multiple different contractile proteins in these small arteries. Based on these exciting new methods, this proposal was designed to explore the main hypothesis that myofilament Ca++ sensitivity is upregulated in immature compared to mature cerebral arteries due to an increased velocity of MLC20 phosphorylation. A corollary hypothesis supported by strong preliminary data predicts that the ultra-structural organization of MLC20 within cerebrovascular smooth muscle is an important determinant of its ability to serve as a substrate for phosphorylation. To address these ideas, three specific aims have been designed: 1) determine substrate- velocity relations for MLC20 phosphorylation in broken cell preparations in the presence and absence of phosphatase inhibitors with age-specific sources of purified ovine MLC20 and synthesized single isoforms of Non-Muscle and Smooth-Muscle MLC20; 2) determine the velocities of MLC20 phosphorylation in intact cell preparations in the presence and absence of phosphatase inhibitors, in response to both spontaneous and standardized cytosolic Ca++ transients; and 3) determine the abundance, distribution, and co-localization of MLC20 in relation to myosin light chain kinase, myosin light chain phosphatase, smooth muscle 1-actin, and myosin heavy chain isoforms. These experiments will be conducted in middle cerebral arteries from term fetal lambs, newborn lambs, and non-pregnant adult sheep to define the effects of postnatal age on these regulatory mechanisms. Further understanding of these mechanisms offers potential to refine clinical strategies for management of infants at risk for cerebrovascular injury, as well as those afflicted by numerous other diseases such as asthma, sepsis, and colitis, in which altered rates of MLC20 phosphorylation are a key factor.
描述(由申请方提供):由于新生儿心血管反应性的独特模式,特别是在脑循环中,心血管不稳定是早产儿临床管理中最困难的挑战之一。与成人动脉相比,未成熟的脑动脉表现出对Ca++内流的依赖性大于对细胞内Ca++释放的依赖性,但也表现出明显增强的肌丝Ca++敏感性。这种增强的胎儿肌丝Ca++敏感性的一个可能的解释是,调节肌球蛋白轻链(MLC 20),一个关键的收缩蛋白,磷酸化在未成熟的脑动脉上调。先前研究MLC 20原位磷酸化的尝试受到技术障碍的限制,包括无法测量完整动脉中MLC 20磷酸化的快速时程。最近在申请人的实验室中开发的方法已经克服了这些问题。定制设计的装置现在可以同时测量细胞溶质Ca++瞬变和MLC 20磷酸化,在一个小到足以容纳胎儿脑动脉的比色皿中的完整动脉中具有毫秒级分辨率。蛋白质表达系统现在可用于生产适合于动力学测量的MLC 20的单一同种型。新的共聚焦共定位方法能够解决这些小动脉中多种不同收缩蛋白之间的相互作用。基于这些令人兴奋的新方法,该提议旨在探索主要假设,即与成熟脑动脉相比,由于MLC 20磷酸化速度增加,未成熟脑动脉中肌丝Ca++敏感性上调。由强有力的初步数据支持的推论假设预测,脑血管平滑肌内MLC 20的超微结构组织是其作为磷酸化底物的能力的重要决定因素。为了解决这些想法,设计了三个具体的目标:1)在存在和不存在磷酸酶抑制剂的情况下,用年龄特异性来源的纯化的绵羊MLC 20和合成的非肌肉和平滑肌MLC 20的单一同种型确定破碎细胞制备物中MLC 20磷酸化的底物-速度关系; 2)在存在和不存在磷酸酶抑制剂的情况下,测定完整细胞制备物中响应自发和标准化胞质Ca++瞬变的MLC 20磷酸化速度;和3)确定MLC 20相对于肌球蛋白轻链激酶、肌球蛋白轻链磷酸酶、平滑肌1-肌动蛋白和肌球蛋白重链同种型的丰度、分布和共定位。这些实验将在足月胎羊、新生羔羊和非妊娠成年绵羊的大脑中动脉中进行,以确定出生后年龄对这些调节机制的影响。对这些机制的进一步了解提供了改进临床策略的潜力,用于管理有脑血管损伤风险的婴儿,以及那些患有许多其他疾病如哮喘,败血症和结肠炎的婴儿,其中MLC 20磷酸化速率的改变是一个关键因素。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William J. Pearce其他文献

The vascular neural network—a new paradigm in stroke pathophysiology
血管神经网络——中风病理生理学的一种新范例
  • DOI:
    10.1038/nrneurol.2012.210
  • 发表时间:
    2012-10-16
  • 期刊:
  • 影响因子:
    33.100
  • 作者:
    John H. Zhang;Jerome Badaut;Jiping Tang;Andre Obenaus;Richard Hartman;William J. Pearce
  • 通讯作者:
    William J. Pearce
Mechanisms of platelet-induced angiospastic reactions: potentiation of calcium sensitivity.
血小板诱导的血管痉挛反应的机制:钙敏感性增强。
Effects of maturation and acute hypoxia on receptor-IP(3) coupling in ovine common carotid arteries.
成熟和急性缺氧对绵羊颈总动脉受体-IP(3) 偶联的影响。

William J. Pearce的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William J. Pearce', 18)}}的其他基金

Gestational Hypoxia and Programming of Maternal, Fetal and Newborn Vascular Function
妊娠期缺氧与母体、胎儿和新生儿血管功能的编程
  • 批准号:
    10650166
  • 财政年份:
    2020
  • 资助金额:
    $ 28.1万
  • 项目类别:
Gestational Hypoxia and Programming of Maternal, Fetal and Newborn Vascular Function
妊娠期缺氧与母体、胎儿和新生儿血管功能的编程
  • 批准号:
    10188626
  • 财政年份:
    2020
  • 资助金额:
    $ 28.1万
  • 项目类别:
Gestational Hypoxia and Programming of Maternal, Fetal and Newborn Vascular Function
妊娠期缺氧与母体、胎儿和新生儿血管功能的编程
  • 批准号:
    10044704
  • 财政年份:
    2020
  • 资助金额:
    $ 28.1万
  • 项目类别:
Gestational Hypoxia and Programming of Maternal, Fetal and Newborn Vascular Function
妊娠期缺氧与母体、胎儿和新生儿血管功能的编程
  • 批准号:
    10455711
  • 财政年份:
    2020
  • 资助金额:
    $ 28.1万
  • 项目类别:
Mechanisms mediating age-dependent inhibition of cerebrovascular MLCK activity and contractility by chronic hypoxia
慢性缺氧对脑血管 MLCK 活性和收缩力的年龄依赖性抑制的介导机制
  • 批准号:
    9072345
  • 财政年份:
    2016
  • 资助金额:
    $ 28.1万
  • 项目类别:
Role of LincRNA in Developmental Regulation of Angiogenesis
LincRNA 在血管生成发育调控中的作用
  • 批准号:
    8885866
  • 财政年份:
    2014
  • 资助金额:
    $ 28.1万
  • 项目类别:
Cerebrovascular Myosin Light Chain Phosphorylation in Fetus, Newborn, and Adult
胎儿、新生儿和成人的脑血管肌球蛋白轻链磷酸化
  • 批准号:
    8332242
  • 财政年份:
    2011
  • 资助金额:
    $ 28.1万
  • 项目类别:
Cerebrovascular Myosin Light Chain Phosphorylation in Fetus, Newborn, and Adult
胎儿、新生儿和成人的脑血管肌球蛋白轻链磷酸化
  • 批准号:
    8222072
  • 财政年份:
    2011
  • 资助金额:
    $ 28.1万
  • 项目类别:
Cerebrovascular Myosin Light Chain Phosphorylation in Fetus, Newborn, and Adult
胎儿、新生儿和成人的脑血管肌球蛋白轻链磷酸化
  • 批准号:
    8640992
  • 财政年份:
    2011
  • 资助金额:
    $ 28.1万
  • 项目类别:
Role of Vascular Endothelial Growth Factor in Hypoxic Remodeling of Ovine Cer
血管内皮生长因子在绵羊神经细胞缺氧重塑中的作用
  • 批准号:
    8015754
  • 财政年份:
    2010
  • 资助金额:
    $ 28.1万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了